| CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults (NCT06962904) | Centers for Disease Control and Prevention | 2025-07-07 |
| CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults (NCT06485258) | Centers for Disease Control and Prevention | 2024-08-06 |
| Short-course Regimens for the Treatment of Pulmonary Tuberculosis (NCT05766267) | Centers for Disease Control and Prevention | 2023-11-21 |
| Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV (NCT06045923) | Centers for Disease Control and Prevention | 2023-03-17 |
| Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP (NCT06054269) | Centers for Disease Control and Prevention | 2022-11-04 |
| Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years (NCT05514002) | Centers for Disease Control and Prevention | 2022-09-13 |
| Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia (NCT06300970) | Centers for Disease Control and Prevention | 2022-08-09 |
| Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine (NCT05460377) | Centers for Disease Control and Prevention | 2022-07-26 |
| Immunogenicity nOPV2 With and Without bOPV (NCT04579510) | Centers for Disease Control and Prevention | 2021-02-08 |
| Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania (NCT04148690) | Centers for Disease Control and Prevention | 2019-11-15 |
| Tuberculosis Clinical Trials Consortium Study 35 (NCT03730181) | Centers for Disease Control and Prevention | 2019-11-12 |
| Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel (NCT04523324) | Centers for Disease Control and Prevention | 2019-10-31 |
| Immunogenicity of Intramuscular and Intradermal IPV (NCT04063150) | Centers for Disease Control and Prevention | 2019-10-06 |
| Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI (NCT03474029) | Centers for Disease Control and Prevention | 2019-08-01 |
| HIV Prevention Among Latina Transgender Women Who Have Sex With Men: Evaluation of a Locally Developed Intervention (NCT03465852) | Centers for Disease Control and Prevention | 2019-07-15 |
| Just-in-time Elastomeric Training and Fit Testing (JET FIT) (NCT03888898) | Centers for Disease Control and Prevention | 2019-04-02 |
| Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study (NCT03722004) | Centers for Disease Control and Prevention | 2018-12-18 |
| Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old (NCT03725618) | Centers for Disease Control and Prevention | 2018-11-01 |
| Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP (NCT03722589) | Centers for Disease Control and Prevention | 2018-09-12 |
| Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea (NCT03535272) | Centers for Disease Control and Prevention | 2018-05-20 |
| Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil (NCT03610399) | Centers for Disease Control and Prevention | 2018-04-09 |
| Duration of IPV Priming and Antibody Decay (NCT03202719) | Centers for Disease Control and Prevention | 2017-11-05 |